HB 1460 — An Act providing for approval from the Department of Health and the Office of Attorney General before certain transactions involving health care entities within this Commonwealth.

PRINTER'S NO.   1696

                    THE GENERAL ASSEMBLY OF PENNSYLVANIA



                        HOUSE BILL
                        No. 1460
                                              Session of
                                                2025

     INTRODUCED BY BOROWSKI, TAKAC, KHAN, BOYD, O'MARA, KRUEGER,
        CURRY, KAZEEM, DELLOSO, YOUNG, HILL-EVANS, GIRAL, FIEDLER,
        SANCHEZ, FREEMAN, PROBST, HOHENSTEIN, DONAHUE, SCHLOSSBERG,
        PROKOPIAK, CEPEDA-FREYTIZ, CERRATO, WAXMAN, DALEY, CIRESI,
        KENYATTA, FRANKEL AND GREEN, MAY 13, 2025

     REFERRED TO COMMITTEE ON HEALTH, MAY 13, 2025


                                    AN ACT
 1   Providing for approval from the Department of Health and the
 2      Office of Attorney General before certain transactions
 3      involving health care entities within this Commonwealth.
 4                            TABLE OF CONTENTS
 5   Chapter 1.   Preliminary Provisions
 6   Section 101.   Short title.
 7   Section 102.   Definitions.
 8   Chapter 3.   Covered Health Care Transactions
 9   Section 301.   Transaction against public interest.
10   Section 302.   Filing of transactions.
11   Section 303.   Public input.
12   Section 304.   Determination and restraining prohibited
13                transactions.
14   Section 305.   Compliance and power of court.
15   Section 306.   Powers and duties of Attorney General.
16   Section 307.   Powers and duties of department.
17   Section 308.   Confidential treatment.
 1   Chapter 10.    Miscellaneous Provisions
 2   Section 1001.     Construction.
 3   Section 1002.     Effective date.
 4      The General Assembly of the Commonwealth of Pennsylvania
 5   hereby enacts as follows:
 6                                   CHAPTER 1
 7                           PRELIMINARY PROVISIONS
 8   Section 101.    Short title.
 9      This act shall be known and may be cited as the Health System
10   Protection Act.
11   Section 102.    Definitions.
12      The following words and phrases when used in this act shall
13   have the meanings given to them in this section unless the
14   context clearly indicates otherwise:
15      "Affected community."       A county within this Commonwealth
16   where an existing health care facility is physically located or
17   a county whose residents are regularly served by the existing
18   health care facility.
19      "Affiliate."     A person that directly or indirectly, through
20   one or more intermediaries, controls or is controlled by, or is
21   under common control with, the person specified.
22      "Against the public interest."         A covered transaction that,
23   as determined by the Attorney General, results in any of the
24   following:
25          (1)     A significant reduction in competition or a
26      significant increase in costs for health care payers,
27      purchasers or consumers.
28          (2)     An unfair method of competition in or affecting
29      health care commerce or an unfair or deceptive act or
30      practice in or affecting health care commerce.

20250HB1460PN1696                      - 2 -
 1          (3)    A significant reduction in the quality of care.
 2          (4)    A significant reduction in access to or availability
 3      of health care services for payers, purchasers or consumers.
 4          (5)    A significant reduction in access to care in a
 5      rural, low-income or disadvantaged community.
 6          (6)    A health care leaseback agreement.
 7      "Attorney General."      The Office of Attorney General of the
 8   Commonwealth.
 9      "Capital distribution."      A payment made, liability incurred
10   or other consideration given by a health care entity to a person
11   for the purchase, acquisition, redemption, repurchase, payment
12   or retirement of capital stock or other equity interest of the
13   health care entity or as a dividend, return of capital or other
14   distribution in respect of the health care entity's capital
15   stock or other equity interest.
16      "Control," "controlled by" or "under common control with."
17   As follows:
18          (1)    The possession, direct or indirect, of the power to
19      direct or cause the direction of the management and policies
20      of a person, whether through the ownership of voting
21      securities, by contract other than a commercial contract for
22      goods or nonmanagement services or otherwise, unless the
23      power is the result of an official position with or corporate
24      office held by the person. Control shall be presumed to exist
25      if a person, directly or indirectly:
26                 (i)    owns more than 10% of a person; or
27                 (ii)    controls, holds with the power to vote or holds
28          proxies representing 10% or more of the votes that all
29          shareholders or members would be entitled to cast in the
30          election of directors or managers.

20250HB1460PN1696                      - 3 -
 1          (2)    The presumption under paragraph (1) may be rebutted
 2      by a showing that control does not exist in fact. The
 3      Attorney General may determine, after furnishing all persons
 4      in interest notice and opportunity to be heard and making
 5      specific findings of fact to support the determination, that
 6      control exists in fact, notwithstanding the absence of a
 7      presumption to that effect or that another person has
 8      control.
 9      "Covered entity."   Includes:
10          (1)    A for-profit entity or an affiliate of a for-profit
11      entity that owns, operates or controls or seeks to own,
12      operate or control a health care entity.
13          (2)    An investor or group of investors who primarily
14      engage in the raising or returning of capital and who invest,
15      develop or dispose of specified assets, a private equity
16      company, a private equity fund or a real estate investment
17      trust or affiliate.
18      "Covered transaction."   A transaction or a series of
19   transactions involving at least one health care entity and one
20   covered entity, and includes any of the following:
21          (1)    The sale, transfer, lease or other encumbrance of a
22      material amount of a health care entity's assets, including
23      real property, employment groups, emergency departments or
24      other units.
25          (2)    A change in control of a health care entity.
26          (3)    A capital distribution or similar reduction of a
27      health care entity's equity capital by a material amount or
28      the incursion of an obligation that commits the health care
29      entity to making a capital distribution or similar reduction
30      of equity by a material amount.

20250HB1460PN1696                   - 4 -
 1      "Department."   The Department of Health of the Commonwealth.
 2      "Health care entity."    The term includes:
 3          (1)   A person that directs, or through an affiliate
 4      directs, control of one or more health care facilities.
 5          (2)   A practitioner organization, representing eight or
 6      more health care practitioners, valued at or above a material
 7      amount.
 8      "Health care facility."    The term shall have the same meaning
 9   as in section 802.1 of the act of July 1, 1979 (P.L.130, No.48),
10   known as the Health Care Facilities Act.
11      "Health care leaseback agreement."     A transaction whereby a
12   person sells, transfers, leases or otherwise encumbers a
13   material amount of the assets or real property of a health care
14   entity and enters into an agreement with another person to lease
15   back the same assets or real property.
16      "Health care practitioner."     The term shall have the same
17   meaning as in section 103 of the Health Care Facilities Act.
18      "Material amount."   An amount equal to $5,000,000 or more.
19      "Practitioner organization."     A person, other than a health
20   care facility, which is in the business of health care delivery
21   or management and that represents health care practitioners in
22   contracting with carriers or third-party administrators for the
23   payment of health care services.
24      "Private equity company."    A nonpublicly traded entity that
25   collects capital investments from individuals or entities.
26      "Private equity fund."    An entity that directly, or through
27   an affiliate, acts as a control person and is any of the
28   following:
29          (1)   A person considered an investment company under 15
30      U.S.C. § 80a-3 (relating to definition of investment

20250HB1460PN1696                   - 5 -
 1      company), except for the application of 15 U.S.C. § 80a-3(c)
 2      (1) and (7).
 3            (2)   A venture capital fund as defined in 17 CFR
 4      275.203(l)-1 (relating to venture capital fund defined).
 5            (3)   A sovereign wealth fund.
 6      "Professional licensing board."      A professional licensing
 7   board within the Bureau of Professional and Occupational Affairs
 8   of the Department of State.
 9      "Real estate investment trust."      The term shall have the same
10   meaning as in 26 U.S.C. § 856 (relating to definition of real
11   estate investment trust).
12                                 CHAPTER 3
13                      COVERED HEALTH CARE TRANSACTIONS
14   Section 301.    Transactions against public interest.
15      (a)   General rule.--Except as provided under subsection (b),
16   a person may not enter into a covered transaction that is
17   against the public interest.
18      (b)   Exception.--An action prohibited under subsection (a)
19   may be permitted when, as determined by the Attorney General,
20   there is no feasible alternative to prevent a health care
21   entity's closure or a greater loss of health care services.
22   Section 302.    Filing of transactions.
23      (a)   Duties of health care entity.--Prior to entering into a
24   covered transaction, a health care entity shall complete one of
25   the following:
26            (1)   file a notification in accordance with subsection
27      (b) and observe the waiting period under subsection (c); or
28            (2)   obtain a written determination from the Attorney
29      General that the covered transaction is not against the
30      public interest.

20250HB1460PN1696                    - 6 -
 1      (b)   Notice.--Notification of a covered transaction shall be
 2   submitted to the Attorney General and the department on a form
 3   and in a manner developed by the Attorney General. The
 4   notification shall include all of the following, as applicable:
 5            (1)   All organic documents, including articles of
 6      incorporation, bylaws, operating agreements and other
 7      documents related to governance and ownership of each party.
 8            (2)   All complete transaction documents with attachments,
 9      including collateral or ancillary agreements involving
10      officers, directors or employees.
11            (3)   All documents signed by the principals, or the
12      principal's agents, that are necessary to determine the
13      proposed transaction's effect, if any, on affiliates, whether
14      nonprofit or for profit.
15            (4)   Any of the following that comprise part or all of
16      the transaction:
17                  (i)    Asset contribution agreements.
18                  (ii)    Operating agreements.
19                  (iii)    Management contracts.
20            (5)   All information necessary to evaluate the effects of
21      the transaction on each component of an integrated delivery
22      system if that transaction involves a hospital, including any
23      changes in contracts between the integrated delivery system
24      entities and related physician groups.
25            (6)   All financial documents of the transaction parties
26      and related entities, if applicable, including audited
27      financial statements, ownership records, business projection
28      data, current capital asset valuation data and any records
29      upon which future earnings, existing asset values and fair
30      market value analysis can be based.

20250HB1460PN1696                       - 7 -
 1        (7)     All fairness opinions and independent valuation
 2    reports of the assets and liabilities of the parties,
 3    prepared on the parties' behalf.
 4        (8)     A list of all donor restricted assets, together with
 5    origination documents and current fund balances.
 6        (9)     All relevant contracts that may affect value,
 7    including business contracts and employee contracts, such as
 8    buy-out provisions, profit-sharing agreements and severance
 9    packages.
10        (10)    All information and representations disclosing
11    related party transactions that are necessary to assess
12    whether the transaction is at arm's length or involves self-
13    dealing.
14        (11)    All documents relating to noncash elements of the
15    transaction, including pertinent valuations of security for
16    loans and stock restrictions.
17        (12)    All tax-related information, including the
18    existence of tax-free debt subject to redemption and
19    disqualified person transactions yielding tax liability.
20        (13)    A list of ongoing litigation, including full court
21    captions, involving the transaction parties or the
22    transaction parties' related entities, that may affect the
23    interests of the parties.
24        (14)    All information in the possession of the
25    transacting parties relative to the perspective of the health
26    care entity's patient base and communities served, or their
27    representatives.
28        (15)    All information, including internal and external
29    reports and studies, bearing on the effect of the proposed
30    transaction on the availability or accessibility of health

20250HB1460PN1696                  - 8 -
 1      care in the affected community.
 2            (16)   A complete list of all insurance plans under
 3      contract and the policies' expiration dates.
 4            (17)   Organizational charts of the parties to the
 5      transaction, as they exist both preconsummation and
 6      postconsummation of the transaction, detailing the
 7      relationship between the principal parties, including any
 8      subsidiary.
 9            (18)   All additional documents that the Attorney General
10      deems necessary for review purposes.
11      (c)   Waiting period.--Prior to entering into a covered
12   transaction, a health care entity shall undergo a 90-day waiting
13   period, which shall begin on the date the Attorney General
14   receives the notification required under subsection (b). Within
15   two business days, the Attorney General shall confirm receipt of
16   the notification with the health care entity that submitted the
17   notification. Upon the expiration of the waiting period provided
18   for under this subsection, and any extension of a waiting period
19   under subsection (d), the covered transaction may proceed unless
20   the Attorney General determines the covered transaction is
21   against the public interest.
22      (d)   Additional information and waiting period extensions.--
23            (1)    The Attorney General may, no later than 30 days
24      prior to the expiration of the waiting period under
25      subsection (c), require the submission of additional
26      information or documentary material from a person who is a
27      party to the proposed covered transaction for which a
28      notification was filed under subsection (b) or from any
29      officer, director, partner, agent or employee of the person.
30            (2)    The Attorney General may, in its discretion, extend

20250HB1460PN1696                     - 9 -
 1      the waiting period under subsection (c) for an additional 30
 2      days for a covered transaction after the date on which the
 3      Attorney General receives either of the following from a
 4      person to whom a request is made under paragraph (1):
 5                  (i)    all of the additional information and
 6            documentary material requested; or
 7                  (ii)    if the request is not fully complied with, the
 8            information and documentary material submitted and a
 9            statement of the reasons for the noncompliance.
10            (3)   Additional extensions of the waiting period beyond
11      what is required under subsection (b) must be granted by a
12      court in accordance with section 305.
13   Section 303.     Public input.
14      (a)   Public hearing.--Prior to the expiration of the
15   respective waiting period under section 302(c), along with any
16   extension granted under section 302(d), the Attorney General may
17   conduct one or more public hearings on the proposed covered
18   transaction.
19      (b)   Accessibility.--
20            (1)   A public hearing required under subsection (a) shall
21      be live-streamed on the Attorney General's publicly
22      accessible Internet website.
23            (2)   A video recording of the public hearing shall be
24      posted on the Attorney General's publicly accessible Internet
25      website.
26      (c)   Specific entities.--If a covered transaction involves
27   the acquisition of a health care facility, the Attorney General
28   may hold a public hearing in any county in which the acquired
29   entity is located to hear comments from interested parties.
30   Interested parties shall include employees of the health care

20250HB1460PN1696                       - 10 -
 1   entity, legal aid organizations, public officials and health
 2   advocacy organizations within a county in which the health care
 3   facility is located. The Attorney General may request testimony
 4   at a hearing from State agencies subject to section 306(d).
 5      (d)   Notice.--At least 14 days before the date of the public
 6   hearing, the Attorney General shall provide written notice of
 7   the date, time and place of the public hearing:
 8            (1)   On the Attorney General's publicly accessible
 9      Internet website.
10            (2)   Through social and broadcast media.
11            (3)   Through publication in one or more newspapers of
12      general circulation in the affected community.
13            (4)   To the governing body of each county in which the
14      health care entity is located.
15      (e)   Substantive changes to proposal.--If a substantive
16   change in the covered transaction is submitted to the Attorney
17   General after the initial public hearing, the Attorney General
18   may conduct an additional public hearing to hear comments from
19   interested parties with respect to the change.
20   Section 304.     Determination and restraining prohibited
21                  transactions.
22      (a)   Determination.--No later than the final date of
23   expiration of the respective waiting period under section
24   302(c), along with any extension granted under section 302(d),
25   the Attorney General shall determine whether the covered
26   transaction is likely to have an impact that is against the
27   public interest.
28      (b)   Department review.--Prior to making a determination
29   whether a covered transaction is against the public interest,
30   the Attorney General shall consult and request feedback from the

20250HB1460PN1696                    - 11 -
 1   department regarding the covered transaction's potential impact
 2   on the existing patient base and affected community.
 3      (c)   Action.--If the Attorney General, in consultation with
 4   the department, determines that the proposed covered transaction
 5   is against the public interest under subsection (a), the
 6   Attorney General, on behalf of the Commonwealth, may:
 7            (1)   commence an action in a court of competent
 8      jurisdiction to enjoin the covered transaction; or
 9            (2)   enter into a voluntary agreement with the covered
10      entity and the health care entity, which shall be filed with
11      Commonwealth Court, that imposes conditions or otherwise
12      mitigates the aspects that make the covered transaction
13      against the public interest.
14      (d)   Monitoring.--
15            (1)   A voluntary agreement entered into under subsection
16      (c) shall include an initial monitoring period of not more
17      than five years. The monitoring period may be extended for
18      additional periods of not more than five years at the
19      discretion of the Attorney General.
20            (2)   The Attorney General shall consult with the
21      department prior to setting the length of the initial
22      monitoring period and any extension.
23            (3)   During the monitoring period, the Attorney General
24      and the department shall monitor, evaluate and assess the
25      covered entity and health care entity's compliance with the
26      terms and conditions of the voluntary agreement.
27      (e)   Costs of monitoring.--
28            (1)   The covered entity shall pay for the costs of the
29      Attorney General and the department's monitoring, evaluation
30      and assessment of the covered entity and health care entity's

20250HB1460PN1696                    - 12 -
 1      compliance with the terms and conditions of the voluntary
 2      agreement during a monitoring period established under
 3      subsection (d).
 4            (2)   The Attorney General, in consultation with the
 5      department, shall determine the amount of the compliance
 6      monitoring cost under this subsection, which shall be paid by
 7      the covered entity and placed in an escrow account during the
 8      monitoring period.
 9      (f)   Licensing.--A health care facility's license may not be
10   revoked, denied, impeded or cited for noncompliance due solely
11   to a filing or review under this chapter.
12   Section 305.    Compliance and power of court.
13      If a person substantially fails to comply with the
14   notification requirement under section 302(a) or any request for
15   the submission of additional information or documentary material
16   under section 302(b) within the respective waiting period under
17   302(c), along with any extension granted under section 302(d),
18   the court may, in its discretion, do any or all of the
19   following:
20            (1)   Order compliance.
21            (2)   Extend the waiting period until there has been
22      substantial compliance.
23            (3)   Grant other equitable relief as the court determines
24      necessary or appropriate.
25   Section 306.    Powers and duties of Attorney General.
26      (a)   Rules and regulations.--The Attorney General, in
27   coordination with the department, shall issue rules and
28   promulgate regulations as may be necessary to carry out and
29   enforce this chapter. The department and the Attorney General
30   shall ensure that the rules and regulations of the department

20250HB1460PN1696                       - 13 -
 1   and the Attorney General are not in conflict.
 2      (b)   Contracts.--
 3            (1)   The Attorney General may do any of the following:
 4                  (i)    Contract with, share information with and
 5            consult and receive advice from any Federal agency or
 6            Commonwealth agency as the Attorney General deems
 7            appropriate to implement this chapter.
 8                  (ii)    At the Attorney General's sole discretion,
 9            contract with experts or consultants to assist in
10            reviewing the proposed covered transaction.
11            (2)   The cost of a contract entered into under paragraph
12      (1) must be an amount that is reasonable and necessary to
13      conduct the review and evaluation and in accordance with the
14      following:
15                  (i)    A contract may be on a noncompetitive bid basis.
16                  (ii)    Upon request, the Attorney General shall be
17            paid promptly for all contract costs by the entities
18            seeking approval or the covered transaction.
19            (3)   The Attorney General shall be entitled to
20      reimbursement from the entities seeking consent for the
21      covered transaction for all actual, reasonable and direct
22      costs incurred in reviewing, evaluating and making a
23      determination under section 304(a), including administrative
24      costs. The entities seeking consent shall promptly pay the
25      Attorney General, upon request, for the costs.
26            (4)   Notwithstanding the other provisions of this act, a
27      covered transaction may not be completed unless an agreement
28      has been executed between the Attorney General and the
29      covered entity, the health care entity or both for the
30      payment of costs in accordance with this subsection.

20250HB1460PN1696                       - 14 -
 1      (c)   Compliance.--If a covered entity or health care entity
 2   enters into a voluntary agreement with the Commonwealth under
 3   section 304(c)(2):
 4            (1)   The Attorney General shall monitor, assess and
 5      evaluate a covered entity and health care entity to ensure
 6      compliance with the terms and conditions of the voluntary
 7      agreement for the duration of the monitoring period
 8      established under section 304(d).
 9            (2)   The Attorney General may request documents and other
10      information from a covered entity or a health care entity, or
11      both, to monitor compliance with the terms of the voluntary
12      agreement under section 304(c). Upon receiving a request from
13      the department, a covered entity or health care entity shall
14      comply with the request within 30 days.
15            (3)   If the Attorney General determines that the health
16      care entity or covered entity has failed to comply with terms
17      of the voluntary agreement, the Attorney General may seek
18      immediate relief in Commonwealth Court to enforce the
19      conditions of the voluntary agreement and may impose any
20      penalties authorized by law or the terms of the voluntary
21      agreement.
22      (d)   Agency cooperation.--
23            (1)   The department, the Department of Aging, the
24      Department of Human Services and the Insurance Department
25      shall assist the Attorney General in reviewing the proposed
26      agreement and transaction, if requested, and shall comply
27      with any request for testimony or information as may be
28      necessary and appropriate for the Attorney General to review
29      a proposed covered transaction.
30            (2)   The Attorney General shall comply with any request

20250HB1460PN1696                     - 15 -
 1      for information from the Insurance Department as may be
 2      necessary and appropriate for the Insurance Department to
 3      concurrently review a proposed transaction under Article XIV
 4      of the act of May 17, 1921 (P.L.682, No.284), known as The
 5      Insurance Company Law of 1921. Documents provided by the
 6      Attorney General to the Insurance Department under this
 7      paragraph shall be treated as confidential and are exempt
 8      from public access under the act of February 14, 2008 (P.L.
 9      6, No.3), known as the Right-to-Know Law.
10            (3)   The Attorney General shall comply with any request
11      for information from the department as may be necessary and
12      appropriate to concurrently review a proposed transaction
13      under the act of July 19, 1979 (P.L.140, No.48), known as the
14      Health Care Facilities Act. Documents provided by the
15      Attorney General to the department under this paragraph shall
16      be treated as confidential and are exempt from public access
17      under the Right-to-Know Law.
18   Section 307.    Powers and duties of department.
19      (a)   Rules and regulations.--The department, in coordination
20   with the Attorney General, shall issues rules and promulgate
21   regulations as may be necessary to carry out and enforce this
22   chapter. The department and the Attorney General shall ensure
23   that the rules and regulations of the department and the
24   Attorney General are not in conflict.
25      (b)   Compliance.--If a health care facility or covered entity
26   enters into a voluntary agreement with the Commonwealth under
27   section 304(c):
28            (1)   The department shall monitor, assess and evaluate a
29      health care facility and covered entity to ensure compliance
30      with the terms and conditions of the voluntary agreement. If

20250HB1460PN1696                    - 16 -
 1      the department determines the health care facility or covered
 2      entity has failed to comply with terms of the voluntary
 3      agreement, the department shall immediately notify the
 4      Attorney General of its findings.
 5             (2)   The department may request documents and other
 6      information from a covered entity, a health care facility or
 7      both to monitor compliance with the terms of the voluntary
 8      agreement under section 304(c). Upon receiving a request from
 9      the department, a covered entity or health care facility
10      shall comply with the request within 30 days.
11             (3)   The department shall be reimbursed from an escrow
12      account established under section 304(e) for costs related to
13      the ongoing monitoring, assessment and evaluation of a health
14      care facility and covered entity's compliance with the terms
15      and conditions of the voluntary agreement during the
16      monitoring period.
17   Section 308.     Confidential treatment.
18      (a)    Confidentiality.--All information, documents, materials
19   and copies thereof in the possession or control of the Attorney
20   General or the department that are produced for, obtained by or
21   disclosed to the Attorney General or the department in the
22   course of a covered entity or health care entity complying with
23   the requirements of section 302(b), 306(c) or (d) or 307(b)
24   shall be privileged and given confidential treatment and shall
25   not be:
26             (1)   Subject to discovery or admissible in evidence in a
27      private civil action.
28             (2)   Subject to subpoena.
29             (3)   Subject to the act of February 14, 2008 (P.L.6,
30      No.3), known as the Right-to-Know Law.

20250HB1460PN1696                     - 17 -
 1            (4)   Made public by the Attorney General, the department
 2      or any other person, except to regulatory or law enforcement
 3      officials of this Commonwealth or other jurisdictions or
 4      experts or consultants under contract with the Attorney
 5      General under section 306(b), without the prior written
 6      consent of the health care entity or covered entity to which
 7      it pertains, unless the Attorney General, after giving the
 8      health entity or covered entity that would be affected notice
 9      and opportunity to be heard, determines that the interest of
10      the public is served by the publication, in which event it
11      may publish all or any part in such manner as it may deem
12      appropriate.
13      (b)   Testifying in a civil action.--The Attorney General, the
14   department, any other Commonwealth agency or any individual or
15   person, who receives documents, materials or other information,
16   while acting under the authority of the Attorney General or the
17   department, or with whom the documents, materials or other
18   information are shared under this chapter, shall not be
19   permitted or required to testify in any private civil action
20   concerning any confidential documents, materials or information
21   covered under this section.
22                                 CHAPTER 10
23                          MISCELLANEOUS PROVISIONS
24   Section 1001.    Construction.
25      This act shall not be construed to:
26            (1)   Narrow, abrogate or otherwise alter the authority of
27      the Attorney General to maintain competitive markets and
28      prosecute or enforce violations of antitrust and unfair trade
29      practices laws.
30            (2)   Narrow, abrogate or otherwise alter the authority of

20250HB1460PN1696                     - 18 -
 1      the department to oversee and approve or disapprove the
 2      change of ownership of or regulate a health care facility
 3      under the act of July 1, 1979 (P.L.130, No.48), known as the
 4      Health Care Facilities Act.
 5          (3)   Narrow, abrogate or otherwise alter the authority of
 6      a professional licensing board to issue, suspend or revoke a
 7      health care practitioners license or regulate the practice of
 8      the health arts in this Commonwealth.
 9          (4)   Prohibit a Federal agency, Commonwealth agency or
10      other state agency from regulating a covered transaction or
11      joining as party in an action seeking to enjoin a covered
12      transaction, including the Insurance Department's
13      jurisdiction to review an exposed transaction under Article
14      XIV of the act of May 17, 1921 (P.L.682, No.284), known as
15      The Insurance Company Law of 1921.
16   Section 1002.   Effective date.
17      This act shall take effect in 60 days.




20250HB1460PN1696                  - 19 -